🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07524907
Recruiting Observational

Stunting and Targeting Reduction of Impaired Growth in Kids Effectively

NCT07524907 · tracked via the Priya Life Science USA tracker
Sponsor
Abbott Nutrition
Phase
Observational
Started
2026-05-11
Last updated
2026-07-24

Condition(s) studied

Malnutrition (Calorie)

Study summary

The objective of this prospective, real-world evidence/pragmatic study with a quality improvement program approach is to evaluate the feasibility and effectiveness of a community-engaged nutrition-focused program utilizing nutrition screening, education, supplementation and continuous follow up for children and their families.

Eligibility

Sex
ALL
Min age
1 Year
Max age
5 Years
Healthy volunteers
No
Household Component Inclusion * Children aged 1-5 years experiencing stunting or its risk (defined as HAZ ≤ -1 SD at baseline) * Children's legal guardian agrees to participate in the study * Full term pregnancy (defined as ≥ 37 weeks gestation and ≥ 2500g birth weight) * Residence in study area attending Children International (NGO) centers Exclusion • Children who have current medical conditions requiring hospitalization: gastrointestinal tract infections or inflammatory bowel disease; active tuberculosis; acute hepatitis B or C; human immunodeficiency virus OR malignancy; cystic fibrosis; immunodeficiency syndromes, congenital abnormalities of the respiratory tract, such as lung and respiratory cilia; an unsuspected foreign body in the respiratory tract; asthma; heart abnormalities; abdominal hernias; and known metabolic disorders, renal impairment, or rheumatic diseases and diabetes * Congenital condition * Children with disabilities such as cerebral palsy, autism spectrum disorder, neurodegenerative disorders * Children with chronic or acute infections e.g. HIV, malaria * Children who are taking medications or other agents that could potentially affect body weight, including diuretics, appetite stimulants, steroids, and growth hormones * Children who have genetic conditions impacting weight status such as but not limited to: Bardet-Biedl Syndrome, Prader-Willi Syndrome * Children already enrolled in a nutrition program that includes a supplement * Participant has an allergy or intolerance to any ingredient in the study supplement, as reported by the parent. * Children with sleep disorders such as but not limited to: obstructive sleep apnea, insomnia, parasomnias (sleepwalking, night terrors, bedwetting), delayed sleep phase syndrome, behavioral sleep disorders, circadian rhythm disorders * Mental health disorders such as but not limited to: anxiety, depression Organization Component Inclusion * NGO staff taking part in nutrition screenings * Agrees to participate in survey Exclusion * Not involved in the implementation of the study * Not involved in working with pediatric stunting or its risk * Declines participation in survey

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Children International Kansas City Missouri Recruiting

More Abbott Nutrition trials in the USA

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07524907 on ClinicalTrials.gov ↗ ← All trials in the USA